Summary:
FDA-approved GRALISE™ (once daily) Phase IV Study
We understand, PAIN and SHINGLES can leave you feeling like a pincushion.
Check out this new study! GRALISE™ was recently approved for the FDA for PHN in the U.S.
Qualified Participants Must:
• Be
18 years of age or older
•
Currently be experiencing postherpetic neuralgia (PHN)
Qualified Participants May Receive:
9 weeks of medication free of cost.
All study-related visits and procedures will also be provided at no cost.